CJC-1295 No DAC for Laboratory Research
CJC-1295 No DAC is listed in the Peptide Lab Sciences catalogue as a research peptide. The compound is also known as Mod GRF 1-29 and is discussed in scientific literature in relation to growth hormone-releasing hormone, or GHRH, receptor signalling.
The current listing provides 2mg and 5mg options. Because the product has more than one variation, researchers should select the strength required by their laboratory purchasing specification rather than assuming that one quantity applies to every listing.
This page explains CJC-1295 No DAC terminology, the distinction between the no-DAC and DAC forms, the relevant scientific context and the documentation that should be reviewed before ordering.
A product description should identify the research subject without making unsupported claims about treatment, performance, bodybuilding, recovery or human administration. CJC-1295 No DAC is presented here as laboratory research material only.
Browse the Research Peptides catalogue to compare related materials. Category placement does not mean that different peptides share the same sequence, stability, activity or intended experimental use.
CJC-1295 No DAC Product Overview
| Product detail | Information |
|---|---|
| Product name | CJC-1295 No DAC (Mod GRF 1-29) |
| Alternative name | Mod GRF 1-29 |
| Research family | GHRH analogue research |
| Available variations | 2mg and 5mg |
| General research context | GHRH receptor and pituitary signalling |
| DAC status | No Drug Affinity Complex stated in the product name |
| Physical format | Confirm from the current specification |
| Sequence information | Review the applicable product documentation |
| Identity and purity | Check available batch documentation |
| Storage and handling | Follow instructions for the supplied preparation |
| Intended use | Laboratory research only |
The table does not establish a production method, purity percentage, biological activity value, stability period, formulation, counterion or administration route.
If any of these details affects your project, request clarification before ordering CJC-1295 No DAC.
What Is CJC-1295 No DAC?
CJC-1295 No DAC is commonly referred to as Mod GRF 1-29. The name indicates a modified form associated with the first 29 residues of growth hormone-releasing hormone research.
Growth hormone-releasing hormone is a hypothalamic signalling molecule that interacts with receptors in the pituitary. Researchers use GHRH-related compounds to study receptor activation, intracellular signalling and the regulation of growth hormone secretion under controlled conditions.
The term “No DAC” distinguishes this listing from CJC-1295 products that include a Drug Affinity Complex. The presence or absence of DAC affects the pharmacokinetic profile being investigated.
Researchers should preserve this distinction in product records. CJC-1295 No DAC and CJC-1295 with DAC should not be treated as interchangeable materials.
A scientific reference to CJC-1295 does not automatically identify which form was used. Read the methods section of each paper carefully.
Understanding Mod GRF 1-29
Mod GRF 1-29 is a common alternative name for CJC-1295 No DAC. The abbreviation can make literature searches easier, but it should not replace the complete material identifier in laboratory records.
Use both terms when searching scientific databases:
- CJC-1295 No DAC
- Mod GRF 1-29
- Modified GRF 1-29
- GHRH 1-29 analogue
When a publication uses one term, preserve that terminology in your notes. Then compare the sequence, modification and preparation details with the product specification.
Similar abbreviations can create confusion when researchers compare supplier pages, journal articles and internal inventory records. A complete identifier helps prevent that problem.
What Does “No DAC” Mean?
DAC refers to the Drug Affinity Complex associated with longer-acting CJC-1295 formulations. The product name states that the listed material is the no-DAC form.
This distinction is relevant because a no-DAC preparation is generally studied separately from a DAC-conjugated form. Differences in structure can affect exposure time, receptor interaction and experimental interpretation.
Do not assume that research involving CJC-1295 with DAC validates CJC-1295 No DAC. Check the exact compound used in the publication.
The no-DAC designation also does not establish a specific half-life for an individual commercial batch. Pharmacokinetic properties depend on the material, method and experimental conditions.
GHRH Receptor Research
CJC-1295 No DAC is associated with research on the GHRH receptor and pituitary signalling. A receptor study may examine adenylate cyclase, cyclic AMP, hormone release or another downstream measurement.
Each endpoint answers a different question. A result involving receptor binding does not automatically establish a long-term physiological effect.
When reviewing CJC-1295 research, record:
- The material used
- The receptor model
- The concentration or exposure condition
- The endpoint measured
- The control group
- The duration
- The limitations described
This record keeps the scientific conclusion connected to the actual experiment.
Published Research on CJC-1295
Research has examined long-acting CJC-1295 analogues and their effects on growth hormone and insulin-like growth factor I secretion in controlled studies.
A publication in healthy adults investigated prolonged stimulation of growth hormone and IGF-I after exposure to a long-acting CJC-1295 analogue. Because the study concerns a defined analogue and formulation, it should not automatically be treated as evidence about every no-DAC product.
Read the primary CJC-1295 study in healthy adults for the original methods and results.
Another study examined whether pulsatile growth hormone secretion persisted during continuous stimulation by CJC-1295. The study provides useful endocrine research context while still requiring careful attention to the exact analogue and protocol.
Read the study of pulsatile growth hormone secretion for its experimental design.
These publications do not certify the CJC-1295 No DAC product listed by Peptide Lab Sciences.
CJC-1295 No DAC and Growth Hormone Signalling
Growth hormone signalling involves a network of hypothalamic, pituitary, hepatic and peripheral processes. GHRH-related research focuses on one part of that network.
A laboratory study may measure growth hormone release from pituitary cells or changes in circulating markers in an animal or human model. Those measurements do not automatically establish clinical benefit.
When reading CJC-1295 No DAC literature, distinguish between:
- Receptor-level observations
- Pituitary cell experiments
- Animal endocrine studies
- Pharmacokinetic investigations
- Human clinical research
- Product qualification data
These categories provide different types of evidence.
Available 2mg and 5mg Variations
The current product listing provides 2mg and 5mg options. Researchers should select the variation that matches the project’s purchasing requirements.
Do not assume that the 2mg and 5mg variations have identical documentation, batch references or preparation details. Review the information attached to the selected option.
The variation selector should be checked before adding the product to the basket. Keep the selected strength in the order record.
If your laboratory requires a specific quantity, confirm that the selected option corresponds with the intended internal reference.
Quantity Does Not Establish Activity
A 2mg or 5mg declaration describes the stated product amount. It does not establish a working concentration, purity percentage, potency or biological activity.
A quantity declaration also does not identify the amount required for an experiment. Working conditions must come from a validated laboratory protocol.
Avoid using the product title as a substitute for a material specification. If a project depends on a particular quantity basis, ask for clarification before purchase.
Seven Essential Checks Before Ordering
1. Confirm the compound form.
Check that your project requires CJC-1295 No DAC rather than a DAC-conjugated product.
2. Confirm the Mod GRF terminology.
Match the product name and relevant sequence description to the material used in your protocol.
3. Select the correct strength.
Choose 2mg or 5mg according to the purchasing requirement.
4. Review the physical format.
Confirm the supplied presentation from the applicable specification.
5. Examine available documentation.
Check identity, batch reference, analytical method and reported results.
6. Confirm handling requirements.
Ensure that the receiving laboratory can manage the preparation under its procedures.
7. Save the purchasing record.
Retain the product page, selected variation, order reference and written clarification.
Product Identity and Documentation
Scientific papers explain how researchers studied an analogue or signalling pathway. Product documentation addresses the material supplied for purchase.
For CJC-1295 No DAC, determine which properties your laboratory needs documented. A statement that a product is “tested” does not identify the test or sample.
If a certificate of analysis is available, review:
- Product identifier
- Selected strength
- Batch number
- Report date
- Analytical method
- Measured result
- Specification limit
- Issuing laboratory
Do not assume that a document for CJC-1295 with DAC applies to the no-DAC form.
Visit the Peptide Lab Sciences quality control page when reviewing available documentation.
Comparing CJC-1295 Products
The catalogue may contain CJC-1295 products with different strengths, blends or DAC status. Compare each listing using a consistent record.
| Comparison field | What to verify |
|---|---|
| Product name | No DAC or DAC form |
| Alternative name | Mod GRF 1-29 or another identifier |
| Strength | 2mg, 5mg or another stated amount |
| Sequence | Confirm against documentation |
| Format | Confirm supplied presentation |
| Batch information | Check applicability |
| Analytical report | Review tests included |
| Handling information | Follow product-specific instructions |
This prevents a similar title from hiding an important difference.
CJC-1295 No DAC Versus CJC-1295 With DAC
The no-DAC and DAC forms are separate research subjects. DAC refers to an added complex intended to alter affinity and exposure characteristics.
Do not combine their evidence in a product description. A publication about one form cannot automatically establish the identity or behaviour of the other.
When reading a study, look for the complete compound name, structural description and preparation method.
If your project requires the no-DAC form, include that wording in the purchasing request and laboratory inventory.
Responsible Laboratory Use
CJC-1295 No DAC is supplied for laboratory research only. It is not offered as a hormone treatment, bodybuilding product, recovery product, supplement or personal administration material.
This page does not provide injection instructions, reconstitution procedures, dosing schedules or medical recommendations.
Researchers are responsible for ensuring that purchase, possession, handling, storage and use comply with applicable law, institutional policy and laboratory safety procedures.
Planning an Institutional Order
Use the full product name CJC-1295 No DAC (Mod GRF 1-29) in the purchase record.
Include the selected strength, such as 2mg or 5mg, and identify any documentation required by your institution.
Add the internal project reference, receiving laboratory and responsible contact.
Check the delivery address and terms shown during checkout.
For clarification, use the Peptide Lab Sciences contact page and identify the exact selected variation.
Receiving the Selected Variation
When the shipment arrives, compare the label with the order record.
Record:
- Complete product name
- Selected strength
- Date received
- Batch reference
- Packaging condition
- Accompanying documents
- Internal inventory number
Document any discrepancy using your laboratory’s receiving procedure.
If the shipment contains a different variation from the one ordered, request clarification before experimental use.
Storage and Handling Information
Follow instructions applicable to the selected CJC-1295 No DAC preparation.
This page does not provide a universal storage temperature, solvent, shelf life or reconstitution method.
Do not transfer instructions from the DAC form or another GHRH analogue merely because the names appear similar.
If your laboratory requires specific handling information, obtain it before ordering and retain it with the product record.
Building a Traceable Research Record
A traceable record should connect the material, strength, supplier and supporting documents.
For CJC-1295 No DAC, retain:
- Full product name
- Product URL
- Selected variation
- Stated strength
- Sequence information
- Batch reference
- Certificate or report
- Relevant PubMed references
- Internal inventory code
If the project changes from 2mg to 5mg or from no-DAC to DAC, record that change explicitly.
Do not allow “CJC-1295” alone to conceal a change in product form.
Reading Endocrine Studies Critically
When reviewing a CJC-1295 paper, identify whether it measured growth hormone, IGF-I, receptor activity or another endpoint.
Record the model used and the timing of measurements. A short-term endocrine response is different from a long-term clinical outcome.
Also check whether the study involved the same structural form as CJC-1295 No DAC.
This approach prevents researchers from combining evidence from unrelated analogues or formulations.
Frequently Asked Questions
1. What is CJC-1295 No DAC?
It is a research peptide commonly associated with Mod GRF 1-29 and GHRH receptor studies.
2. What does “No DAC” mean?
It identifies the form without the Drug Affinity Complex stated in the product name.
3. What strengths are available?
The current listing provides 2mg and 5mg options. Select the required variation from the product page.
4. Is Mod GRF 1-29 another name?
Yes, Mod GRF 1-29 is commonly used as an alternative research name. Verify the exact material specification.
5. Is CJC-1295 No DAC a medicine?
No. It is presented for laboratory research only and is not offered as a licensed medicine or treatment.
6. Does 2mg or 5mg describe a dose?
No. It describes the stated product quantity and does not provide an administration instruction.
7. Is no-DAC the same as DAC?
No. They are separate research forms and should be compared using their exact identifiers.
8. Does the product title confirm the sequence?
No. Review the current specification for sequence information.
9. Does published research validate this product?
No. Scientific studies describe their own materials and methods. They do not certify an individual commercial batch.
10. Does the product come with a certificate of analysis?
Check the documentation available for the selected variation and supplied batch.
11. Is CJC-1295 No DAC intended for bodybuilding?
No personal-use claim is made. The product is supplied for laboratory research only.
12. Can I combine evidence from CJC-1295 with DAC?
Do not assume that evidence transfers between forms. Compare the structures and methods first.
13. How should the product be stored?
Follow instructions applicable to the actual preparation supplied and your laboratory procedures.
14. Does the listing provide injection instructions?
No. This page does not provide administration or injection instructions.
15. Can I request additional documentation?
Yes. Contact Peptide Lab Sciences with the complete product name and selected strength.
16. Is the product a peptide blend?
No blend claim is made for this listing. Confirm the product composition from the current specification.
17. Does the price establish product quality?
No. Price does not independently establish identity, purity or biological activity.
18. Where can I compare other research peptides?
Visit the Research Peptides category and assess each listing individually.
19. Can I switch between the 2mg and 5mg options after ordering?
Confirm the selected variation before checkout. If a change is needed, contact the supplier through the contact page.
20. Is CJC-1295 No DAC intended for human or veterinary use?
No. It is supplied for laboratory research only and is not intended for consumption, injection, diagnosis or treatment.
Review CJC-1295 No DAC Before Ordering
Select CJC-1295 No DAC by confirming the exact form, Mod GRF 1-29 terminology, selected strength and available documentation.
The 2mg and 5mg options should be treated as separate purchasing choices. Record the selected variation in your order and inventory documents.
Read the linked PubMed studies for their actual material, model and limitations. Keep scientific references separate from product qualification records.
For product questions, contact Peptide Lab Sciences before ordering and include the full product name and selected strength.
For laboratory research only. Not for human or veterinary use, consumption, injection, diagnosis, treatment or personal administration.
Reviews
There are no reviews yet.